North America CRISPR Gene Editing market is projected to grow by 24.4% annually in the forecast period and reach $5,976.7 million by 2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.
Highlighted with 28 tables and 50 figures, this 118-page report “North America CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America CRISPR Gene Editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America CRISPR Gene Editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Country.
Based on Offering, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• CRISPR Products
o Kits & Enzymes
Vector-Based Cas9
DNA-Free Cas9
o Databases & Libraries
o Design Tools
o Antibodies
o CRISPR Plasmid & Vector
o Other Products
• CRISPR Services
o gRNA Design & Vector Construction
o Cell Line Engineering
o Microbial Gene Editing
o DNA Synthesis
o Other Services
Based on Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Biomedical Research & Therapy
o Gene Therapy
o Drug Discovery
o Diagnostics
o Other Biomedical Applications
• Agriculture
• Industrial Use
• Other Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical Companies
• Biotechnology Companies
• Academic Institutions & Research Centers
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Offering, Application, and End User, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 22
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 35
2.4 Emerging Opportunities and Market Trends 38
2.5 Porter’s Fiver Forces Analysis 42
3 Segmentation of North America Market by Offering 46
3.1 Market Overview by Offering 46
3.2 CRISPR Products 48
3.2.1 Kits & Enzymes 50
3.2.2 Databases & Libraries 51
3.2.3 Design Tools 52
3.2.4 Antibodies 53
3.2.5 CRISPR Plasmid & Vector 54
3.2.6 Other Products 55
3.3 CRISPR Services 56
3.3.1 gRNA Design & Vector Construction 58
3.3.2 Cell Line Engineering 59
3.3.3 Microbial Gene Editing 60
3.3.4 DNA Synthesis 61
3.3.5 Other Services 62
4 Segmentation of North America Market by Application 63
4.1 Market Overview by Application 63
4.2 Biomedical Research & Therapy 65
4.2.1 Gene Therapy 67
4.2.2 Drug Discovery 68
4.2.3 Diagnostics 69
4.2.4 Other Biomedical Applications 70
4.3 Agriculture 71
4.4 Industrial Use 72
4.5 Other Applications 73
5 Segmentation of North America Market by End User 74
5.1 Market Overview by End User 74
5.2 Pharmaceutical Companies 76
5.3 Biotechnology Companies 77
5.4 Academic Institutions & Research Centers 78
5.5 Other End Users 79
6 North America Market 2021-2031 by Country 80
6.1 Overview of North America Market 80
6.2 U.S. 83
6.3 Canada 86
6.4 Mexico 88
7 Competitive Landscape 89
7.1 Overview of Key Vendors 90
7.2 New Product Launch, Partnership, Investment, and M&A 94
7.3 Company Profiles 95
Abcam, Inc. 95
Agilent Technologies, Inc. 97
Applied StemCell, Inc. 98
Caribou Biosciences, Inc. 99
Cellecta, Inc. 100
CRISPR Therapeutics AG 101
Editas Medicine, Inc. 102
GeneCopoeia, Inc. 103
GeneScript Biotech Corporation 104
Horizon Discovery Group PLC 105
Integrated DNA Technologies, Inc. 106
Intellia Therapeutics Inc. 107
Lonza Group Ltd. 108
Merck KGaA 109
New England Biolabs, Inc. 110
Origene Technologies, Inc. 111
Rockland Immunochemicals, Inc. 112
Synthego Corporation 113
System Biosciences LLC 114
Takara Bio, Inc. 115
Thermo Fisher Scientific, Inc. 116
ToolGen, Inc. 117
RELATED REPORTS 118
List of Tables:
Table 1. Snapshot of North America CRISPR Gene Editing Market in Balanced Perspective, 2021-2031 18
Table 2. World Economic Outlook, 2021-2031 23
Table 3. Developing Roadmap of CRISPR Technology 27
Table 4. Private and Public Companies Investment in CRISPR Technology 28
Table 5. Comparison of CRISPR with Other Gene Editing Technologies 31
Table 6. World Health Spending by Region, $ bn, 2013-2020 34
Table 7. Main Product Trends and Market Opportunities in North America CRISPR Gene Editing Market 38
Table 8. North America CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 46
Table 9. North America CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn 49
Table 10. North America CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn 50
Table 11. North America CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn 57
Table 12. North America CRISPR Gene Editing Market by Application, 2021-2031, $ mn 63
Table 13. North America CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn 66
Table 14. North America CRISPR Gene Editing Market by End User, 2021-2031, $ mn 74
Table 15. North America CRISPR Gene Editing Market by Country, 2021-2031, $ mn 81
Table 16. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 85
Table 17. U.S. CRISPR Gene Editing Market by Application, 2021-2031, $ mn 85
Table 18. U.S. CRISPR Gene Editing Market by End User, 2021-2031, $ mn 85
Table 19. Canada CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 87
Table 20. Canada CRISPR Gene Editing Market by Application, 2021-2031, $ mn 87
Table 21. Canada CRISPR Gene Editing Market by End User, 2021-2031, $ mn 87
Table 22. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 89
Table 23. Mexico CRISPR Gene Editing Market by Application, 2021-2031, $ mn 89
Table 24. Mexico CRISPR Gene Editing Market by End User, 2021-2031, $ mn 89
Table 25. Breakdown of World Market by Key Vendor, 2021, % 92
Table 26. Abcam, Inc.: Company Snapshot 95
Table 27. Abcam, Inc.: Business Segmentation 96
Table 28. Abcam, Inc.: Product Portfolio 96
